Gene-editing specialist Seamless Therapeutics has attracted its first major pharma partner, Eli Lilly, with a $1.12 billion alliance that will seek out therapies for hearing loss.

Godiva Festival will not be held at War Memorial Park for the first time since 1997 The head of events at Coventry City Council said "it's not all over" as Godiva Festival is set to be replaced with a ...

Bianca Censori took “bareback” riding very literally. The architect and performance artist, 31, sat for her first in-depth interview for Vanity Fair, revealing more than skin as she finally spoke ...

Coventry City Council has announced new events after the Godiva Festival was scrapped. The beloved festival has been 'paused' this year amid funding issues and industry challenges. The council said it ...

Godiva Festival in Coventry has been scrapped for 2026. Coventry City Council announced the annual event will be 'paused' this year amid rising costs and industry challenges. Tom Grennan, The Enemy, ...

Coventry's Godiva Festival will not take place this year, the BBC has learned. It will instead be replaced with an event called "Godiva in the City", a free city centre event. The city council is to ...

Coventry's Godiva Festival will not take place this year, the BBC has learned. It will instead be replaced with an event called "Godiva in the City", a free city centre event. The city council is ...

The “Say it With Godiva,” Valentine’s Day campaign features actress and singer Leighton Meester, who is reprising her portrayal of Lady Godiva. Godiva is celebrating love, craftsmanship and indulgence ...

In case you've faced some hurdles solving the clue, Seamless transitions, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and ...

Eli Lilly & Co. struck a deal worth more than $1.1 billion with German biotech Seamless Therapeutics GmbH to develop gene therapies for hearing loss. Closely-held Seamless will design a type of enzyme ...

-- Collaboration will advance a next generation gene editing approach by combining Seamless’ expertise in developing highly precise and efficient recombinases with Lilly’s extensive development ...